Literature DB >> 27873122

How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?

Sait Ashina1, Jes Olesen2, Richard B Lipton3.   

Abstract

Classification has played a major role in the diagnosis of primary headache conditions including migraine with and without aura. With many updates and changes, the International Classification of Headache Disorders (ICHD)-3 beta is currently considered as the gold standard for classification of migraine and other headaches. Correct diagnosis of migraine and its subtypes is a first step toward appropriate treatment and crucial to minimizing disability and optimizing health-related quality of life. The ICHD-3 beta version represents the state of the art in migraine diagnosis but is expected to evolve as biological knowledge advances. Future research should focus on identification of biologically homogeneous subgroups of migraine based on genes and biomarkers.

Entities:  

Keywords:  Classifications; Diagnosis; ICHD; Management; Migraine

Mesh:

Year:  2016        PMID: 27873122     DOI: 10.1007/s11916-016-0599-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  24 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Authors:  H C Diener; D W Dodick; S K Aurora; C C Turkel; R E DeGryse; R B Lipton; S D Silberstein; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 3.  Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines.

Authors:  Matthew S Robbins; Amaal J Starling; Tamara M Pringsheim; Werner J Becker; Todd J Schwedt
Journal:  Headache       Date:  2016-07       Impact factor: 5.887

4.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

5.  Problem areas in the International Classification of Headache Disorders, 3rd edition (beta).

Authors:  Jes Olesen
Journal:  Cephalalgia       Date:  2014-05-16       Impact factor: 6.292

6.  Retinal migraine reappraised.

Authors:  B M Grosberg; S Solomon; D I Friedman; R B Lipton
Journal:  Cephalalgia       Date:  2006-11       Impact factor: 6.292

Review 7.  Migraine aura: new ideas about cause, classification, and clinical significance.

Authors:  Andrew Charles; Jakob Møller Hansen
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

8.  Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study.

Authors:  S Silberstein; E Loder; S Diamond; M L Reed; M E Bigal; R B Lipton
Journal:  Cephalalgia       Date:  2007-03       Impact factor: 6.292

9.  Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging.

Authors:  Todd J Schwedt; Catherine D Chong; Teresa Wu; Nathan Gaw; Yinlin Fu; Jing Li
Journal:  Headache       Date:  2015-06       Impact factor: 5.887

10.  Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers.

Authors:  D C Buse; A Manack; D Serrano; C Turkel; R B Lipton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-17       Impact factor: 10.154

View more
  2 in total

1.  Familial hemiplegic migraine in a child with seizure disorder: clinical history is the key to diagnosis.

Authors:  Pranav Balakrishnan; Phalguna Kousika Katakam; Asha P Hegde
Journal:  BMJ Case Rep       Date:  2019-03-25

2.  Frequency of migraine according to the ICHD-3 criteria and its association with sociodemographic and triggering factors in Pakistan: A cross-sectional study.

Authors:  Farwa Athar; Afra Zahid; Minaam Farooq; Muhammad Ayyan; Mohammad Ashraf; Mukarram Farooq; Faiza Naeem; Aamna Badar; Muhammad Ehsan; Ayesha Hussain; Muhammad Abdullah Ilyas
Journal:  Ann Med Surg (Lond)       Date:  2022-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.